Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 4,579 | 7,887 | 8,488 | 5,392 | 6,215 |
| Operating Income | -4,579 | -7,887 | -8,488 | -5,392 | -6,215 |
| Other Income | 133 | 161 | 172 | 227 | 307 |
| Pre-tax Income | -4,446 | -7,726 | -8,316 | -5,165 | -5,908 |
| Income Tax | N/A | N/A | N/A | N/A | -424 |
| Net Income Continuous | -4,446 | -7,726 | -8,316 | -5,165 | -5,484 |
| Net Income | $-4,446 | $-7,726 | $-8,316 | $-5,165 | $-5,484 |
| EPS Basic Total Ops | 6.03 | -6.81 | -10.72 | -7.53 | -7.63 |
| EPS Basic Continuous Ops | 6.03 | -6.81 | -10.72 | -7.53 | -7.85 |
| EPS Diluted Total Ops | 6.03 | -6.81 | -10.72 | -7.53 | -7.63 |
| EPS Diluted Continuous Ops | 6.03 | -6.81 | -10.72 | -7.53 | -7.85 |
| EPS Diluted Before Non-Recurring Items | N/A | -6.81 | -5.50 | N/A | N/A |
| EBITDA(a) | $-4,552 | $-6,328 | $-4,382 | $-5,353 | $-6,176 |